Activator protein-2α functions as a master regulator of multiple transcription factors in the mouse liver

Hepatology Research

Volumn 41, Issue 8, 2011, Pages 776-783

  Li, Qingjie ^a   Luo, Cunhui ^e,f   Löhr, Christiane V ^b   Dashwood, Roderick H ^c,d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Department of Veterinary Clinical Medicine   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d OREGON STATE UNIVERSITY   (United States)

^e HUNAN AGRICULTURAL UNIVERSITY   (China)

^f Hunan Provincial Institute for Drug Control   (China)

Author keywords

Activator protein AP 2; Activator protein 1; GATA4 transcription factor; Liver; Protein kinase A

Indexed keywords

ACTIVATOR PROTEIN 2 ALPHA; CCAAT BINDING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEPATOCYTE NUCLEAR FACTOR 1; MYC PROTEIN; PROTEIN C MYB; PROTEIN KINASE B; RETINOID X RECEPTOR; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; IMMUNOBLOTTING; IN VIVO GENE TRANSFER; LIVER; LIVER CELL NUCLEUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MICROARRAY; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 79960742247     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00827.x     Document Type: Article

References (39)

1. Jonckheere N, Fauquette V, Stechly L etal. Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression. Br J Cancer 2009; 101: 637-44.
2. Eckert D, Buhl S, Weber S, Jäger R, Schorle H. The AP-2 family of transcription factors. Genome Biol 2005; 6: 246.
3. O'Brien EK, Alençon C, Bonde G etal. Transcription factor Ap-2-alpha is necessary for development of embryonic melanophores, autonomic neurons and pharyngeal skeleton in zebrafish. Dev Biol 2004; 265: 246-61.
4. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 1996; 381: 235-8.
5. Williams T, Admon A, Luscher B, Tjian R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 1988; 2: 1557-69.
6. Ren Y, Liao WS. Transcription factor AP-2 functions as a repressor that contributes to the liver-specific expression of serum amyloid A1 gene. J Biol Chem 2001; 276: 17770-8.
7. Orso F, Penna E, Cimino D etal. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J 2008; 22: 2702-14.
8. Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 2000; 260: 1-12.
9. Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM, Kosma VM. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J Clin Oncol 1998; 16: 3584-91.
10. Li Q, Dashwood RH. Activator protein 2α associates with adenomatous polyposis coli/β-catenin and inhibits β-catenin/T-cell factor transcriptional activity in colorectal cancer cells. J Biol Chem 2004; 279: 45669-75.
11. Ropponen KM, Kellokoski JK, Pirinen RT etal. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas: comparison of immunohistochemistry and in situ hybridisation. J Clin Pathol 2001; 54: 533-8.
12. Ruiz M, Troncoso P, Bruns C, Bar-Eli M. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Clin Cancer Res 2001; 7: 4086-95.
13. Douglas DB, Akiyama Y, Carraway H etal. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Res 2004; 64: 1611-20.
14. Ding X, Luo C, Zhou J etal. The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation. J Cell Biochem 2009; 106: 285-95.
15. Zhao F, Lufkin T, Gelb BD. Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis. Gene Expr Patterns 2003; 3: 213-17.
16. Moser M, Rüschoff J, Buettner R. Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. Dev Dyn 1997; 208: 115-24.
17. Chazaud C, Oulad-Abdelghani M, Bouillet P, Décimo D, Chambon P, Dollé P. AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 1996; 54: 83-94.
18. Uchida C, Oda T, Sugiyama T, Otani S, Kitagawa M, Ichiyama A. The role of Sp1 and AP-2 in basal and protein kinase A - induced expression of mitochondrial serine:pyruvate aminotransferase in hepatocytes. J Biol Chem 2002; 277: 39082-92.
19. Lowell CA, Stearman RS, Morrow JF. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 1986; 261: 8453-61.
20. Pyper SR, Viswakarma N, Yu S, Reddy JK. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal 2010; 8: e002.
21. Patient RK, McGhee JD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 2002; 12: 416-22.
22. Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 2005; 25: 1215-27.
23. Watt AJ, Battle MA, Li J, Duncan SA. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci U S A 2004; 101: 12573-8.
24. Holtzinger A, Evans T. Gata4 regulates the formation of multiple organs. Development 2005; 132: 4005-14.
25. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 2002; 9: 279-89.
26. Duncan SA. Generation of embryos directly from embryonic stem cells by tetraploid embryo complementation reveals a role for GATA factors in organogenesis. Biochem Soc Trans 2005; 33: 1534-6.
27. Li Q, Löhr CV, Dashwood RH. Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse. Cancer Lett 2009; 283: 36-42.
28. Yu Z, Loehr CV, Fischer KA etal. In utero exposure of mice to dibenzo[a, l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res 2006; 66: 755-62.
29. Li Q, Dashwood WM, Zhong X, Al-fageeh M, Dashwood RH. Cloning of the rat beta-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Genomics 2004; 83: 231-42.
30. Turner BC, Zhang J, Gumbs AA etal. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 1998; 58: 5466-72.
31. Cole MD, Nikiforov MA. Transcriptional activation by the Myc oncoprotein. Curr Top Microbiol Immunol 2006; 302: 33-50.
32. Zima T, Kalousova M. Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol Clin Exp Res 2005; 29: 110S-5S.
33. Bode AM, Ma WY, Surh YJ, Dong Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 2001; 61: 850-3.
34. Ameyar M, Wisniewska M, Weitzman JB. A role for AP-1 in apoptosis: the case for and against. Biochimie 2003; 85: 747-52.
35. Siu YT, Jin DY. CREB-a real culprit in oncogenesis. FEBS J 2007; 274: 3224-32.
36. Conkright MD, Montminy M. CREB: the unindicted cancer co-conspirator. Trends Cell Biol 2005; 15: 457-9.
37. Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005; 16: 137-47.
38. Minegishi N, Suzuki N, Kawatani Y, Shimizu R, Yamamoto M. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway. Genes Cells 2005; 10: 693-704.
39. Hernandez-Hernandez A, Ray P, Litos G etal. Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J 2006; 25: 3264-74.